EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Prevalence of a Composite Outcome to Capture Child and Liver Health One Year After Pediatric Liver Transplantation in the Starzl Network

Frank DiPaola iD, Amy Feldman iD, Vicky Ng iD, Swati Antala iD, John Bucuvalas iD, Noelle Ebel iD, Nitika Gupta iD, Jennifer Halma iD, Rohit Kohli iD, Daniel Leung, Steven Lobritto iD, Anna Peters iD und 2 weitere

Pediatric Transplantation · 2026

DOI: 10.1111/petr.70402 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Transplantation, 2026. Verfasst von Frank DiPaola und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Department of Pediatrics, University of Virginia, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Liver Transplantation, Immunosuppression Therapy, Immunosuppressive Agents, Postoperative Complications. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: F DiPaola.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Starzl Network for Excellence in Pediatric Transplantation, a learning health network focused on pediatric liver transplantation, identified optimizing immunosuppression as a priority challenge. There remains significant variability in immunosuppression practices across transplant centers and a need for comparative effectiveness research to clarify best practices. As a prelude, we aimed to develop a composite outcome that focuses on immunosuppression‐related morbidity and to characterize its baseline prevalence at 1 year post‐liver transplant.

Methods

We developed a composite transplant primary outcome, based on a previously described “ideal outcome” definition utilized by the Society of Pediatric Liver Transplantation registry studies, with components reflecting liver and child health. We used retrospective data from Starzl Network centers to calculate the prevalence of achieving the composite outcome among children who underwent a liver transplant in 2023.

Results

In 2023, 19 participating centers transplanted a total of 267 children. Of the 250 with complete data available, 46% were < 2 years of age at transplant, 25% were 2–8 years, 22% were > 8 years, and 7% were missing age data. Seventy‐eight children (31%) achieved the composite outcome at 1 year, including 35% of < 2‐year‐olds, 32% of 2–8 year‐olds, 29% of > 8 year‐olds, and 11% without age available. The most common failed composite outcome criterion was having ALT > 50 IU/L at 1 year.

Conclusions

Only 31% of pediatric liver transplant recipients achieved the composite outcome by 1 year. Our network will aim to develop evidence‐based best practices to increase achievement of the composite outcome by “right‐sizing” immunosuppression for each child.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationImmunosuppression TherapyImmunosuppressive AgentsPostoperative ComplicationsChild HealthHumansChild, PreschoolChildRetrospective StudiesFemaleMalePrevalenceInfantRegistriesTreatment OutcomeAdolescent

Stichwörter der Autor:innen

comparative effective trialscomposite outcomeimmunosuppressionpatient‐centered outcomespediatric liver transplantation

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Division of Pediatric Gastroenterology, Department of Pediatrics, University of Virginia, Charlottesville, Virginia, USA.
  • Section of Pediatric Gastroenterology, Hepatology and Nutrition, Digestive Health Institute, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
  • Division of Gastroenterology, Hepatology and Nutrition, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Mount Sinai Kravis Children's Hospital and Recanati/Miller Transplantation Institute, Mount Sinai Health System, New York, New York, USA.
  • Stanford University, Palo Alto, California, USA.
  • Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, USA.

ORCID-Profile: Frank DiPaola, Amy Feldman, Vicky Ng, Swati Antala, John Bucuvalas, Noelle Ebel, Nitika Gupta, Jennifer Halma, Rohit Kohli, Steven Lobritto, Anna Peters, James Squires, Emily Perito

Förderung

  • F DiPaola

Zitieren

APA

DiPaola, F., Feldman, A., Ng, V., Antala, S., Bucuvalas, J., Ebel, N., Gupta, N., Halma, J., Kohli, R., Leung, D., Lobritto, S., Peters, A., Squires, J., & Perito, E. (2026). Prevalence of a Composite Outcome to Capture Child and Liver Health One Year After Pediatric Liver Transplantation in the Starzl Network. Pediatric Transplantation. https://doi.org/10.1111/petr.70402

Vancouver

DiPaola F, Feldman A, Ng V, Antala S, Bucuvalas J, Ebel N, et al. Prevalence of a Composite Outcome to Capture Child and Liver Health One Year After Pediatric Liver Transplantation in the Starzl Network. Pediatric Transplantation. 2026. doi:10.1111/petr.70402

BibTeX
@article{DiPaola2026,
  author = {DiPaola, Frank and Feldman, Amy and Ng, Vicky and Antala, Swati and Bucuvalas, John and Ebel, Noelle and Gupta, Nitika and Halma, Jennifer and Kohli, Rohit and Leung, Daniel and Lobritto, Steven and Peters, Anna and Squires, James and Perito, Emily},
  title = {Prevalence of a Composite Outcome to Capture Child and Liver Health One Year After Pediatric Liver Transplantation in the Starzl Network},
  journal = {Pediatric Transplantation},
  year = {2026},
  doi = {10.1111/petr.70402}
}
Kostenlos starten →